autoimmuner/r adult ALLApprovedFDA/MHRA/EMA approvedUSUKEUPediatric B-ALLPhase 2CATULUSSystemic Lupus ErythematosusPhase 1CARLYSLE AUTO1/22CD19 & CD22 / dual-targeting autologous CAR T-cell therapy / Hematology/oncologyPediatric B-ALLPhase 1CARPALL AUTO8BCMA & CD19 / autologous CAR T-cell therapy / Hematology/oncologyMultiple MyelomaPhase 1MCARTYLight Chain AmyloidosisPhase 1ALARIC AUTO4/5TRBC1/2 / programmed T-cell therapy / Hematology/oncologyTRBC1/2+ Peripheral TCLPreclinicalLibrA T1 AUTO6NGGD2 / autologous CAR T-cell therapy / Solid tumorsNeuroblastomaPhase 1MAGNETO AUTO9programmed T-cell therapy / Hematology/oncologyAcute Myeloid LeukemiaPreclinicalTBD 6assets AXS-05AXS-05 / AUVELITY / NMDA receptor
A recent study conducted by researchers at the University of Pennsylvania analyzed more than 400,000 Reddit posts to identify patient-reported side effects associated with GLP-1 drugs, including Ozempic (semaglutide) and tirzepatide
Those are brand names what we prescribe is compounded semaglutide and tirzepatide, the same active medications behind them, dosed and supervised by our medical team
Cardiovascular effects and tolerability of GLP-1 receptor agonists: a systematic review and meta-analysis of 99,599 patients
HR, 0.62 [95% CI, 0.55-0.70]
In this paper we develop a mathematical model for APAP metabolism that allows us to study, in silico , how various doses of APAP are metabolized and whether or not a dose exceeds the capacity of the liver to synthesize sufficient GSH